A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 12, 2008, Pages 1371-1376

  Sasaki, Hidefumi ^a   Okuda, Katsuhiro ^a   Takada, Minoru ^b   Kawahara, Masaaki ^b   Kitahara, Naoto ^b   Matsumura, Akihide ^b   Iuchi, Keiji ^b   Kawaguchi, Tomoya ^b   Kubo, Akihiko ^b   Endo, Katsuhiko ^a   Kawano, Osamu ^a   Yukiue, Haruhiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

D1012H; EGFR; Exon 25; Lung cancer; Polymorphism

Indexed keywords

GEFITINIB;

ADENOSQUAMOUS CARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; EXON; FEMALE; GENE DELETION; GENE INSERTION; HUMAN; JAPANESE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RECEPTOR GENE; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOMATIC MUTATION;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; EXONS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; SURVIVAL RATE;

EID: 54949158368     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0411-5     Document Type: Article

References (28)

1. PJ Bertics GN Gill 1985 Self-phospholylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor J Biol Chem 260 14642 14647
2. PJ Bertics WS Chen L Hubler CS Lazar MG Rosenfeld GN Gill 1988 Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation J Biol Chem 263 3610 3617
3. K Cheng JG Koland 1996 Nucleotide binding by the epidermal growth factor receptor protein-tyrosine kinase. Trinitrophenyl-ATP as a spectroscopic probe J Biol Chem 271 311 318
4. K Endo A Konishi H Sasaki M Takada H Tanaka M Okumura M Kawahara H Sugiura Y Kuwabara I Fukai A Matsumura M Yano Y Kobayashi K Mizuno H Haneda E Suzuki K Iuchi Y Fujii 2005 Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay Lung Cancer 50 375 384
5. M Fukuoka S Yano G Giaccone T Tamura K Nakagawa JY Douillard Y Nishiwaki J Vansteenkiste S Kudoh D Rischin R Eek T Horai K Noda I Takata E Smit S Averbuch A Macleod A Feyereuslova RP Dong J Baselga 2003 Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 2237 2246
6. T Fukushima F Favereaux H Huang T Shimizu Y Yonekawa Y Nakazato H Ohagki 2006 Genetic alterations in primary glioblastomas in Japan J Neuropathol Exp Neurol 65 12 18
7. Ginsberg RJ, Kris K, Armstrong G (1993) Cancer of the lung. In: Principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 673-682
8. D Kang G Gridley WY Huang LS Engel DM Winn LM Brown E Bravo-Otero T Wu SR Diehl RB Hayes 2005 Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico Pharmacogenet Genomics 15 343 347
9. T Kosaka Y Yatabe H Endoh H Kuwano T Takahashi T Mitsudomi 2004 Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications Cancer Res 64 8919 8923
10. MG Kris RB Natale RS Herbst TJ Lynch D Prager CP Belani JH Schiller K Kelly H Spiridonidis A Sandler KS Albain D Cella MK Wolf SD Averbuch JJ Ochs AC Kay 2003 Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non small cell lung cancer: randomized trial JAMA 290 2149 2158
11. M Landau SJ Fleishman N Ben-Tal 2004 A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains Structure 12 2265 2275
12. NY Lee TL Hazlett JG Koland 2006 Structure and dynamics of the epidermal growth factor receptor C-terminal phopshorylation domain Protein Sci 15 1142 1152
13. G Liu S Gurubhagavatula W Zhou Z Wang BY Yeap K Asomaning L Su R Heist TJ Lynch DC Christiani 2008 Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib Pharmacogenomics J 8 129 138
14. TJ Lynch DW Bell R Sordella S Gurubhagavatula RA Okimoto BW Branniga PL Harris SM Haserlat JG Supko FG Haluska DN Louis DC Christiani J Settleman DA Haber 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib New Engl J Med 350 2129 2139
15. A Marchetti C Martella L Felicioni F Barassi S Salvatore A Chella PP Camplese T Iarussi F Muchilli A Mezzetti F Cuccurullo R Sacco F Buttitta 2005 EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment J Clin Onlol 23 857 865
16. VA Miller MG Kris N Shah J Patel C Azzoli J Gomez LM Krug W Pao N Rizvi B Pizzo L Tyson E Venkatraman L Ben-Porat N Memoli M Zakowski V Rusch RT Heelan 2004 Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer J Clin Oncol 22 1103 1109
17. RI Nicolson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37 S9 S15
18. A Onn AM Correa M Gilcrease T Isobe E Massarelli CD Bucane MS O'Reilly WK Hong IJ Fidler JB Putnum RS Herbst 2004 Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer Clin Cancer Res 10 136 143
19. JG Paez PA Janne JC Lee S Tracy H Greulich S Gabriel P Herman FJ Kaye N Lindeman TJ Boggon K Naoki H Sasaki Y Fujii MJ Eck WR Seller BE Johnson M Meyerson 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497 1500
20. W Pao V Miller M Zakowski J Doherty K Politi I Sarkari R Heelan V Rusch L Fulton E Mardis D Kupfer R Wilson M Kri H Varmus 2004 EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and elrotinib Proc Natl Acad Sci USA 101 13306 13311
21. H Sasaki K Endo A Konishi M Takada M Kawahara K Iuchi A Matsumura M Okumura H Tanaka T Kawaguchi T Shimizu H Takeuchi M Yano I Fukai Y Fujii 2005 EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LighyCycler Clin Cancer Res 11 2924 2929
22. H Sasaki S Shimizu K Endo M Takada M Kawahara H Tanaka A Matsumura K Iuchi H Haneda E Suzuki Y Kobayashi M Yano Y Fujii 2006 EGFR and erbB2 mutation status in Japanese lung cancer patients Int J Cancer 118 180 184
23. H Shigematsu L Lin T Takahashi M Numura M Suzuki II Wistuba KM Fong H Lee S Toyooka N Shimizu T Fujisawa Z Feng JA Roth J Herz JD Minna AF Gazdar 2005 Clinical and biological features associated with epidermal growth factor receptor gene mutation in lung cancers J Natl Cancer Inst 97 339 346
24. S Shintani K Matsuo CC Crohin J McBride T Tsuji RB Donoff M Posner R Todd DT Wong 1999 Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes Cancer Res 59 4142 4147
25. N Thatcher A Chang P Purvish J Rodrigues Pereira T Ciuleanu J von Pawel EH Tan K Pemberton V Archer K Carroll 2005 Gefitinib plus best supportive care in previously treated patients with refractory advance non-small-cell lung cancer: result from a randomized, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Lancet 366 1527 1537
26. M Tokumo S Toyooka K Kiura H Shigematsu K Tomii M Aoe K Ichimura T Tsuda M Yano K Tsukuda M Tabata H Ueoka M Tanimoto H Date AF Gazder N Shimizu 2005 The relationship between epidermal growth factor receptor mutation and clinicopathological feature in non-small cell lung cancers Clin Cancer Res 11 1167 1173
27. W Zhang LP Stabile P Keohavong M Romkes JR Grandis A Traynor JM Siegfried 2006 Mutation and polymorphism in the EGFR-TK domain associated with lung cancer J Thorac Oncol 1 635 646
28. Q Wang F Zhu Z Wang 2007 Identification of EGF receptor C-terminal sequence 1005-1017 and di-leucine motif (1010) LL(1011) as essential in EGF receptor endocytosis Exp Cell Res 313 3349 3363